THE NEXT GENERATION OF BRILLIANCE

An enhanced system designed for a versatile, comprehensive, and smart treatment session

FEATURES

PRECISE

Intelligent Optical Tracking® System
Ensures uniform treatment delivery with built-in safety measures so that administering treatments is reliable and easy

VERSATILE

Dual Wavelength Enabled Treatment Credit Key
Use both wavelengths on the same treatment credit

COMPREHENSIVE

Cradle for Both Handpieces
Seamlessly switch between handpieces to provide a customized and comprehensive treatment

PATIENT CHARTING

Export patient treatment chart via USB

EASY

User-Friendly Touchscreen
Intuitive navigation

SMART

Charting Assistant
Track treatment progress

SIMPLE

Training Mode
Simulate treatment without emitting laser energy

COMPACT

Small and transportable, can fit on a tabletop, making it easy to maneuver in the practice

SYSTEM SPECIFICATIONS

Laser Type Original Perméa Spot Size Predefined Settings
Diode Fractional 1440nm 1927nm 140µm/mtz Low - Medium - High
LaserDiode
TypeFractional
Original1440nm
Perméa1927nm
Spot Size140µm/mtz
Predefined SettingsLow - Medium - High

MTZ - microscopic treatment zone

CLOSE

INDICATION

Clear + Brilliant® laser system (1440nm and 1927nm handpieces) is indicated for dermatological procedures requiring the coagulation of soft tissue and general skin resurfacing.

IMPORTANT SAFETY INFORMATION

  • The following contraindications are routine for many laser treatments and may also be associated with non-ablative Clear + Brilliant® laser system treatments. Pre-screening should include, but not be limited to:
    • Diagnosis / possibility of actinic keratosis, melasma, rosacea, or other significant skin conditions (e.g., skin cancer, active infections, cold sores, open wounds, rashes, burns, inflammation, eczema, psoriasis);
    • Predisposition to keloid formation or excessive scarring;
    • Diagnosis of a condition that may compromise the immune system, such as HIV, lupus, scleroderma, or systemic infections;
    • Known sensitivity to light or if photosensitizing agents or medications are being taken;
    • Systemic steroids (e.g., prednisone, dexamethasone), which should be rigorously avoided prior to and throughout the course of treatment;
    • Use of retinoids, which should be avoided for at least 2 weeks prior to and during treatment;
    • Patients undergoing isotretinoin acne treatment or with drugs in a similar class;
    • Whether skin is still recovering from a cosmetic procedure, such as a chemical or mechanical peel, or laser resurfacing; and
    • Whether botulinum toxin injections, or dermal fillers (such as collagen) have occurred within the past 2 weeks.
Improper use of Clear + Brilliant® may cause personal injury or damage to the system. See the Operator Manual for detailed directions, proper use, and full risk and safety information. For additional product information see clearandbrilliant.com/hcp.
CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.